IP Library Granted Patent US 12,337,196
Granted Patent B2
US 12,337,196 · App. 18/480,900 · Granted Jun 24, 2025

Systems and methods for shuttle mode radiation delivery

Inventors: Debashish Pal (Sunnyvale, CA); Ayan Mitra (Dublin, CA); Christopher Eric Brown (Morgan Hill, CA); Peter Demetri Olcott (Los Gatos, CA); Yevgen Voronenko (San Jose, CA); Rostem Bassalow (Lacey, WA)
Assignee: RefleXion Medical, Inc.
A61N5/1031A61N5/1001A61N5/1045A61N5/1049A61N5/1065A61N5/1067A61N5/1069A61N5/107A61N5/1081A61N2005/1019A61N5/1036A61N5/1039A61N2005/1041A61N5/1075
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,337,196
App. No.
18/480,900
Granted
Jun 24, 2025
Kind
B2
Abstract

Systems and methods for shuttle mode radiation delivery are described herein. One method for radiation delivery comprises moving the patient platform through the patient treatment region multiple times during a treatment session. This may be referred to as patient platform or couch shuttling (i.e., couch shuttle mode). Another method for radiation delivery comprises moving the therapeutic radiation source jaw across a range of positions during a treatment session. The jaw may move across the same range of positions multiple times during a treatment session. This may be referred to as jaw shuttling (i.e., jaw shuttle mode). Some methods combine couch shuttle mode and jaw shuttle mode. Methods of dynamic or pipelined normalization are also described.

Claims (27)

1. A method for updating a treatment plan fluence map, the method comprising:

acquiring PET imaging data originating from a target region using PET detectors;

identifying a location of the target region from the acquired PET imaging data; and

updating a treatment plan fluence map for irradiating the target region using the identified location, wherein updating the treatment plan fluence map comprises scaling a planned fluence using one or more of a normalization factor, a dampening factor, and a weighting factor.

2. The method of claim 1 , wherein the PET detectors comprise time-of-flight PET detectors.

3. The method of claim 1 , further comprising acquiring MV detector data, and wherein updating the treatment plan fluence map uses the acquired MV detector data.

4. The method of claim 1 , further comprising delivering radiation to the target region according to the updated treatment plan fluence map using a therapeutic radiation source.

5. The method of claim 4 , wherein delivering radiation to the target region comprises adjusting a speed of a couch while the therapeutic radiation source is emitting radiation.

6. The method of claim 1 , wherein delivering radiation occurs in at least two separate passes of a couch through radiation emitted by a therapeutic radiation source.

7. The method of claim 6 , wherein updating the treatment plan fluence map comprises updating the treatment plan fluence map after a first couch pass and updating the treatment plan fluence map after a second couch pass.

8. The method of claim 7 , wherein the normalization factor is dynamically updated for the second couch pass based on radiation delivered during the first couch pass.

9. The method of claim 1 , wherein updating the treatment plan fluence map comprises updating radiotherapy system instructions, wherein radiotherapy system instructions comprise one or more of jaw, multi-leaf collimator, couch, and/or gantry instructions.

10. The method of claim 1 , further comprising calculating a fluence previously delivered to the target region and comparing the previously delivered fluence to the treatment plan fluence map to calculate a fluence difference, and wherein updating the treatment plan fluence map comprises adjusting radiation delivery to deliver the calculated fluence difference.

11. The method of claim 10 , further comprising determining dose artifacts in the previously delivered fluence, and wherein updating the treatment plan fluence map comprises adjusting radiation delivery to correct the dose artifacts.

12. The method of claim 1 , wherein acquiring PET data, identifying the location of the target region, and updating the treatment plan fluence map occur during a single treatment session.

13. The method of claim 1 , wherein the normalization factor and/or dampening factor and/or weighting factor are determined based on an intensity of the PET imaging data originating from the target region.

14. A method for updating a treatment plan fluence map, the method comprising:

acquiring PET imaging data originating from a target region using PET detectors;

calculating a fluence previously delivered to the target region;

comparing the previously delivered fluence to a treatment plan fluence map to determine dose artifacts in the previously delivered fluence; and

updating the treatment plan fluence map by adjusting radiation delivery to correct the dose artifacts.

15. The method of claim 14 , wherein the PET detectors comprise time-of-flight PET detectors.

16. The method of claim 14 , further comprising acquiring MV detector data, and wherein updating the treatment plan fluence map uses the acquired MV detector data.

17. The method of claim 14 , further comprising delivering radiation to the target region according to the updated treatment plan fluence map using a therapeutic radiation source.

18. The method of claim 17 , wherein delivering radiation to the target region comprises adjusting a speed of a couch while the therapeutic radiation source is emitting radiation.

19. The method of claim 17 , wherein delivering radiation occurs in at least two separate passes of a couch through radiation emitted by the therapeutic radiation source.

20. The method of claim 19 , wherein updating the treatment plan fluence map comprises updating the treatment plan fluence map after a first couch pass and updating the treatment plan fluence map after a second couch pass.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2024
From: PAL, DEBASHISH; MITRA, AYAN; BROWN, CHRISTOPHER ERIC; OLCOTT, PETER DEMETRI; VORONENKO, YEVGEN; BASSALOW, ROSTEM
To: REFLEXION MEDICAL, INC.
Reel/Frame 066954/0769 →
Continuity (6)
Continuation 17877719 · Jul 29, 2022
Continuation 17150977 · Jan 15, 2021
Continuation 16814867 · Mar 10, 2020
Continuation 16138631 · Sep 21, 2018
Provisional Application 62562212 · Sep 22, 2017
Related Publication 20240173568A1 · May 30, 2024
References Cited (378)
US 3794840A · Scott · 1974 [cited by applicant]
US 5394452A · Swerdloff et al. · 1995 [cited by applicant]
US 5511549A · Legg et al. · 1996 [cited by applicant]
US 5813985A · Carroll · 1998 [cited by applicant]
US 6023494A · Senzig et al. · 2000 [cited by applicant]
US 6038283A · Carol et al. · 2000 [cited by applicant]
US 6393096B1 · Carol et al. · 2002 [cited by applicant]
US 6438202B1 · Olivera et al. · 2002 [cited by applicant]
US 6455856B1 · Gagnon · 2002 [cited by applicant]
US 6459762B1 · Wong et al. · 2002 [cited by applicant]
US 6459769B1 · Cosman · 2002 [cited by applicant]
US 6504899B2 · Pugachev et al. · 2003 [cited by applicant]
US 6661870B2 · Kapatoes et al. · 2003 [cited by applicant]
US 6700949B2 · Susami et al. · 2004 [cited by applicant]
US 6735277B2 · McNutt et al. · 2004 [cited by applicant]
US 7015490B2 · Wang et al. · 2006 [cited by applicant]
US 7020233B1 · Tybinkowski et al. · 2006 [cited by applicant]
US 7085347B2 · Mihara et al. · 2006 [cited by applicant]
US 7177386B2 · Mostafavi et al. · 2007 [cited by applicant]
US 7191100B2 · Mostafavi · 2007 [cited by applicant]
US 7265356B2 · Pelizzari et al. · 2007 [cited by applicant]
US 7266175B1 · Romesberg · 2007 [cited by applicant]
US 7302033B2 · Carrano et al. · 2007 [cited by applicant]
US 7302038B2 · Mackie et al. · 2007 [cited by applicant]
US 7343030B2 · Sawyer · 2008 [cited by applicant]
US 7356112B2 · Brown et al. · 2008 [cited by applicant]
US 7367955B2 · Zhang et al. · 2008 [cited by applicant]
US 7453984B2 · Chen et al. · 2008 [cited by applicant]
US 7469035B2 · Keall et al. · 2008 [cited by applicant]
US 7496181B2 · Mazin et al. · 2009 [cited by applicant]
US 7508967B2 · Harari et al. · 2009 [cited by applicant]
US 7513861B2 · Klein et al. · 2009 [cited by applicant]
US 7522779B2 · Fu et al. · 2009 [cited by applicant]
US 7611452B2 · Allison et al. · 2009 [cited by applicant]
US 7620444B2 · Le et al. · 2009 [cited by applicant]
US 7623623B2 · Raane et al. · 2009 [cited by applicant]
US 7639853B2 · Olivera et al. · 2009 [cited by applicant]
US 7649981B2 · Seppi et al. · 2010 [cited by applicant]
US 7657304B2 · Mansfield et al. · 2010 [cited by applicant]
US 7693257B2 · Allison · 2010 [cited by applicant]
US 7711087B2 · Mostafavi · 2010 [cited by applicant]
US 7715606B2 · Jeung et al. · 2010 [cited by applicant]
US 7769430B2 · Mostafavi · 2010 [cited by applicant]
US 7783335B2 · Le Corre · 2010 [cited by applicant]
US 7820989B2 · Sommer · 2010 [cited by applicant]
US 7831073B2 · Fu et al. · 2010 [cited by applicant]
US 7869862B2 · Seppi et al. · 2011 [cited by applicant]
US 7906770B2 · Otto · 2011 [cited by applicant]
US 7945021B2 · Shapiro et al. · 2011 [cited by applicant]
US 7949095B2 · Ning et al. · 2011 [cited by applicant]
US 7983380B2 · Guertin et al. · 2011 [cited by applicant]
US 8017915B2 · Mazin · 2011 [cited by applicant]
US 8019042B2 · Shukla et al. · 2011 [cited by applicant]
US 8060177B2 · Hamill · 2011 [cited by applicant]
US 8063376B2 · Maniawski et al. · 2011 [cited by applicant]
US 8086004B2 · Kuduvalli et al. · 2011 [cited by applicant]
US 8090074B2 · Filiberti et al. · 2012 [cited by applicant]
US 8148703B2 · Sommer · 2012 [cited by applicant]
US 8149991B2 · Moreau · 2012 [cited by applicant]
US 8193508B2 · Shchory et al. · 2012 [cited by applicant]
US 8260013B2 · Pekar et al. · 2012 [cited by applicant]
US 8295430B2 · Zhu et al. · 2012 [cited by applicant]
US 8295435B2 · Wang et al. · 2012 [cited by applicant]
US 8295906B2 · Saunders et al. · 2012 [cited by applicant]
US 8303505B2 · Webler et al. · 2012 [cited by applicant]
US 8311185B2 · Seppi et al. · 2012 [cited by applicant]
US 8331532B2 · Nord et al. · 2012 [cited by applicant]
US 8442287B2 · Fordyce, II et al. · 2013 [cited by applicant]
US 8457372B2 · Fu et al. · 2013 [cited by applicant]
US 8461538B2 · Mazin · 2013 [cited by applicant]
US 8509383B2 · Lu et al. · 2013 [cited by applicant]
US 8536547B2 · Maurer, Jr. et al. · 2013 [cited by applicant]
US 8559596B2 · Thomson et al. · 2013 [cited by applicant]
US 8571639B2 · Mostafavi · 2013 [cited by applicant]
US 8588367B2 · Busch et al. · 2013 [cited by applicant]
US 8594769B2 · Mostafavi · 2013 [cited by applicant]
US 8699664B2 · Otto et al. · 2014 [cited by applicant]
US 8716669B2 · Myaoka et al. · 2014 [cited by applicant]
US 8748825B2 · Mazin · 2014 [cited by applicant]
US 8767917B2 · Ruchala et al. · 2014 [cited by applicant]
US 8788020B2 · Mostafavi et al. · 2014 [cited by applicant]
US 8824630B2 · Maurer, Jr. et al. · 2014 [cited by applicant]
US 8831706B2 · Fu et al. · 2014 [cited by applicant]
US 8841628B2 · Kitano et al. · 2014 [cited by applicant]
US 8861672B2 · Maltz et al. · 2014 [cited by applicant]
US 8874187B2 · Thomson et al. · 2014 [cited by applicant]
US 8917813B2 · Maurer, Jr. · 2014 [cited by applicant]
US 9155909B2 · Ishikawa · 2015 [cited by applicant]
US 9205281B2 · Mazin · 2015 [cited by applicant]
US 9232928B2 · Mostafavi · 2016 [cited by applicant]
US 9248312B2 · Li et al. · 2016 [cited by applicant]
US 9456764B2 · Burke et al. · 2016 [cited by applicant]
US 9616251B2 · Filiberti et al. · 2017 [cited by applicant]
US 9731148B2 · Olivera et al. · 2017 [cited by applicant]
US 9820700B2 · Mazin · 2017 [cited by applicant]
US 9849308B2 · Berlinger et al. · 2017 [cited by applicant]
US 9990711B2 · Lugosi et al. · 2018 [cited by applicant]
US 10065049B2 · Lugosi et al. · 2018 [cited by applicant]
US 10279196B2 · West et al. · 2019 [cited by applicant]
US 10327716B2 · Mazin · 2019 [cited by applicant]
US 10406382B2 · Humber et al. · 2019 [cited by applicant]
US 10449389B2 · Ollila et al. · 2019 [cited by applicant]
US 10617888B2 · Pal et al. · 2020 [cited by applicant]
US 10646188B2 · Mostafavi et al. · 2020 [cited by applicant]
US 10688320B2 · Voronenko et al. · 2020 [cited by applicant]
US 10695586B2 · Harper et al. · 2020 [cited by applicant]
US 10737118B2 · Mostafavi · 2020 [cited by applicant]
US 10799716B2 · Morgas et al. · 2020 [cited by applicant]
US 10806368B2 · Hebert · 2020 [cited by applicant]
US 10835761B2 · Beriault et al. · 2020 [cited by applicant]
US 10912950B2 · Pal et al. · 2021 [cited by applicant]
US 10918885B2 · Haas et al. · 2021 [cited by applicant]
US 10959686B2 · Mazin · 2021 [cited by applicant]
US 11033757B2 · Voronenko et al. · 2021 [cited by applicant]
US 11083913B2 · Lachaine et al. · 2021 [cited by applicant]
US 11154269B2 · Shea et al. · 2021 [cited by applicant]
US 11173324B2 · Paysan et al. · 2021 [cited by applicant]
US 11278737B2 · Peltola et al. · 2022 [cited by applicant]
US 11291858B2 · MacDonald et al. · 2022 [cited by applicant]
US 11309072B2 · Carmi · 2022 [cited by applicant]
US 11358008B2 · Voronenko et al. · 2022 [cited by applicant]
US 11369805B2 · Maltz · 2022 [cited by applicant]
US 11369806B2 · Laurence, Jr. et al. · 2022 [cited by applicant]
US 11439844B2 · Pal et al. · 2022 [cited by applicant]
US 11478662B2 · Sayeh et al. · 2022 [cited by applicant]
US 11504548B2 · Fong de los Santos et al. · 2022 [cited by applicant]
US 11504550B2 · Maolinbay · 2022 [cited by applicant]
US 11520415B2 · Douglas et al. · 2022 [cited by applicant]
US 11596807B2 · Maurer et al. · 2023 [cited by applicant]
US 11617903B2 · Lamb et al. · 2023 [cited by applicant]
US 11627920B2 · Mazin · 2023 [cited by applicant]
US 11633626B2 · Voronenko et al. · 2023 [cited by applicant]
US 11642027B2 · Otto · 2023 [cited by applicant]
US 11684801B2 · Schadewaldt et al. · 2023 [cited by applicant]
US 11801398B2 · Voronenko et al. · 2023 [cited by applicant]
US 11813481B2 · Pal et al. · 2023 [cited by applicant]
US 11896848B2 · Janardhanan et al. · 2024 [cited by applicant]
US 12115386B2 · Voronenko et al. · 2024 [cited by applicant]
US 12167922B2 · Mazin · 2024 [cited by applicant]
US 12233286B2 · Voronenko et al. · 2025 [cited by applicant]
US 20020191734A1 · Kojima et al. · 2002 [cited by applicant]
US 20030036700A1 · Weinberg · 2003 [cited by applicant]
US 20030058984A1 · Susami et al. · 2003 [cited by applicant]
US 20030128801A1 · Eisenberg et al. · 2003 [cited by applicant]
US 20030219098A1 · McNutt et al. · 2003 [cited by applicant]
US 20040024300A1 · Graf · 2004 [cited by applicant]
US 20040030246A1 · Townsend et al. · 2004 [cited by applicant]
US 20040037390A1 · Mihara et al. · 2004 [cited by applicant]
US 20040057557A1 · Nafstadius · 2004 [cited by applicant]
US 20040096033A1 · Seppi et al. · 2004 [cited by applicant]
US 20040116804A1 · Mostafavi · 2004 [cited by applicant]
US 20040120452A1 · Shapiro et al. · 2004 [cited by applicant]
US 20040184579A1 · Mihara et al. · 2004 [cited by applicant]
US 20040218719A1 · Brown et al. · 2004 [cited by applicant]
US 20040264640A1 · Myles · 2004 [cited by applicant]
US 20050089135A1 · Toth et al. · 2005 [cited by applicant]
US 20050109939A1 · Engler et al. · 2005 [cited by applicant]
US 20050111621A1 · Riker et al. · 2005 [cited by applicant]
US 20050111757A1 · Brackett et al. · 2005 [cited by applicant]
US 20050113961A1 · Sabol et al. · 2005 [cited by applicant]
US 20050197564A1 · Dempsey · 2005 [cited by applicant]
US 20050201509A1 · Mostafavi et al. · 2005 [cited by applicant]
US 20050201510A1 · Mostafavi · 2005 [cited by applicant]
US 20050207531A1 · Dempsey et al. · 2005 [cited by applicant]
US 20060002511A1 · Miller et al. · 2006 [cited by applicant]
US 20060058637A1 · Sommer · 2006 [cited by applicant]
US 20060113482A1 · Pelizzari et al. · 2006 [cited by applicant]
US 20060159220A1 · Heuscher · 2006 [cited by applicant]
US 20060182326A1 · Schildkraut et al. · 2006 [cited by applicant]
US 20060193435A1 · Hara et al. · 2006 [cited by applicant]
US 20060237652A1 · Kimchy et al. · 2006 [cited by applicant]
US 20060241332A1 · Klein et al. · 2006 [cited by applicant]
US 20060293583A1 · Saracen et al. · 2006 [cited by applicant]
US 20070003010A1 · Guertin et al. · 2007 [cited by applicant]
US 20070003123A1 · Fu et al. · 2007 [cited by applicant]
US 20070014391A1 · Mostafavi et al. · 2007 [cited by applicant]
US 20070025496A1 · Brown et al. · 2007 [cited by applicant]
US 20070025524A1 · Yue · 2007 [cited by applicant]
US 20070075273A1 · Birgy et al. · 2007 [cited by applicant]
US 20070133749A1 · Mazin et al. · 2007 [cited by applicant]
US 20070153969A1 · Maschke · 2007 [cited by applicant]
US 20070165779A1 · Chen et al. · 2007 [cited by applicant]
US 20070167801A1 · Webler et al. · 2007 [cited by applicant]
US 20070237290A1 · Mostafavi · 2007 [cited by applicant]
US 20070242801A1 · Mackie et al. · 2007 [cited by applicant]
US 20070265528A1 · Xu et al. · 2007 [cited by applicant]
US 20080002811A1 · Allison · 2008 [cited by applicant]
US 20080031406A1 · Yan et al. · 2008 [cited by applicant]
US 20080071131A1 · Rietzel · 2008 [cited by applicant]
US 20080095416A1 · Jeung et al. · 2008 [cited by applicant]
US 20080128631A1 · Suhami · 2008 [cited by applicant]
US 20080156993A1 · Weinberg et al. · 2008 [cited by applicant]
US 20080205588A1 · Kim · 2008 [cited by applicant]
US 20080230705A1 · Rousso et al. · 2008 [cited by applicant]
US 20080273659A1 · Guertin et al. · 2008 [cited by applicant]
US 20090088622A1 · Mostafavi · 2009 [cited by applicant]
US 20090116616A1 · Lu et al. · 2009 [cited by applicant]
US 20090169082A1 · Mizuta et al. · 2009 [cited by applicant]
US 20090296886A1 · Maltz et al. · 2009 [cited by applicant]
US 20100049030A1 · Saunders et al. · 2010 [cited by applicant]
US 20100054411A1 · Nord et al. · 2010 [cited by applicant]
US 20100150309A1 · Nord et al. · 2010 [cited by applicant]
US 20100266099A1 · Busch et al. · 2010 [cited by applicant]
US 20110073763A1 · Subbarao · 2011 [cited by applicant]
US 20110122997A1 · Lu et al. · 2011 [cited by applicant]
US 20110150186A1 · Ziegler · 2011 [cited by examiner]
US 20110291015A1 · Mazin · 2011 [cited by applicant]
US 20110301449A1 · Maurer, Jr. · 2011 [cited by applicant]
US 20120020449A1 · Yan et al. · 2012 [cited by applicant]
US 20120043481A1 · Mansfield et al. · 2012 [cited by applicant]
US 20120053961A1 · Wang et al. · 2012 [cited by applicant]
US 20120189102A1 · Maurer, Jr. et al. · 2012 [cited by applicant]
US 20120230464A1 · Ling et al. · 2012 [cited by applicant]
US 20130083004A1 · Nord et al. · 2013 [cited by applicant]
US 20130158382A1 · Chao · 2013 [cited by applicant]
US 20130188856A1 · Adler, Jr. et al. · 2013 [cited by applicant]
US 20130279658A1 · Mazin · 2013 [cited by applicant]
US 20130336449A1 · Tanabe · 2013 [cited by applicant]
US 20140105355A1 · Toimela et al. · 2014 [cited by applicant]
US 20140321615A1 · Carlsson · 2014 [cited by applicant]
US 20140348297A1 · Burshtein et al. · 2014 [cited by applicant]
US 20140371581A1 · Mostafavi et al. · 2014 [cited by applicant]
US 20150043709A1 · Shapiro et al. · 2015 [cited by applicant]
US 20160023019A1 · Filiberti et al. · 2016 [cited by applicant]
US 20160038767A1 · Wiersma et al. · 2016 [cited by applicant]
US 20160140300A1 · Purdie · 2016 [cited by examiner]
US 20160331997A1 · Vilsmeier · 2016 [cited by applicant]
US 20160361566A1 · Larkin et al. · 2016 [cited by applicant]
US 20170028221A1 · Kontaxis et al. · 2017 [cited by applicant]
US 20170084025A1 · Lyu · 2017 [cited by applicant]
US 20170087385A1 · Miettinen et al. · 2017 [cited by applicant]
US 20170209715A1 · Ruebel et al. · 2017 [cited by applicant]
US 20170252579A1 · Kilby · 2017 [cited by applicant]
US 20180133508A1 · Pearce et al. · 2018 [cited by applicant]
US 20180133518A1 · Harper et al. · 2018 [cited by applicant]
US 20180154179A1 · Ollila et al. · 2018 [cited by applicant]
US 20190001152A1 · O'Connor et al. · 2019 [cited by applicant]
US 20190054315A1 · Isola et al. · 2019 [cited by applicant]
US 20190070436A1 · Willcut et al. · 2019 [cited by applicant]
US 20190255362A1 · Voronenko et al. · 2019 [cited by applicant]
US 20190381338A1 · Voronenko et al. · 2019 [cited by applicant]
US 20210128947A1 · Pal et al. · 2021 [cited by applicant]
US 20210196212A1 · Mazin · 2021 [cited by applicant]
US 20210236854A1 · Voronenko et al. · 2021 [cited by applicant]
US 20210327560A1 · Carmi · 2021 [cited by applicant]
US 20220126117A1 · Voronenko et al. · 2022 [cited by applicant]
US 20230087425A1 · Pal et al. · 2023 [cited by applicant]
US 20230337991A1 · Mazin · 2023 [cited by applicant]
US 20240316363A1 · Voronenko et al. · 2024 [cited by applicant]
US 20250032818A1 · Voronenko et al. · 2025 [cited by applicant]
CN 1681436A · 2005 [cited by applicant]
CN 1824342A · 2006 [cited by applicant]
CN 1960780A · 2007 [cited by applicant]
CN 101267767A · 2008 [cited by applicant]
CN 103180014A · 2013 [cited by applicant]
CN 104284697A · 2015 [cited by applicant]
CN 105658279A · 2016 [cited by applicant]
CN 106563211A · 2017 [cited by applicant]
CN 107072595A · 2017 [cited by applicant]
CN 107072628A · 2017 [cited by applicant]
EP 0212135B1 · 1991 [cited by applicant]
EP 1454653B1 · 2007 [cited by applicant]
EP 3175886B1 · 2018 [cited by applicant]
JP 2905995B2 · 1999 [cited by applicant]
JP H11290466A · 1999 [cited by applicant]
JP 2005261941A · 2005 [cited by applicant]
JP 2007502166A · 2007 [cited by applicant]
JP 2007507246A · 2007 [cited by applicant]
JP 2009502249A · 2009 [cited by applicant]
JP 2011528977A · 2011 [cited by applicant]
JP 2016174674A · 2016 [cited by applicant]
JP 2017199876A · 2017 [cited by applicant]
WO WO9428971A2 · 1994 [cited by applicant]
WO WO9428971A3 · 1994 [cited by applicant]
WO WO03018132A1 · 2003 [cited by applicant]
WO WO03076003A2 · 2003 [cited by applicant]
WO WO03076003A3 · 2003 [cited by applicant]
WO WO2004017832A2 · 2004 [cited by applicant]
WO WO2004017832A3 · 2004 [cited by applicant]
WO WO2004105574A2 · 2004 [cited by applicant]
WO WO2004105574A3 · 2004 [cited by applicant]
WO WO2005018734A2 · 2005 [cited by applicant]
WO WO2005018734A3 · 2005 [cited by applicant]
WO WO2005018735A2 · 2005 [cited by applicant]
WO WO2005018735A3 · 2005 [cited by applicant]
WO WO2005031629A1 · 2005 [cited by applicant]
WO WO2005110495A1 · 2005 [cited by applicant]
WO WO2006051531A2 · 2006 [cited by applicant]
WO WO2006051531A3 · 2006 [cited by applicant]
WO WO2006086765A2 · 2006 [cited by applicant]
WO WO2006086765A3 · 2006 [cited by applicant]
WO WO2007082126A2 · 2007 [cited by applicant]
WO WO2007082126A3 · 2007 [cited by applicant]
WO WO2007120674A2 · 2007 [cited by applicant]
WO WO2007120674A3 · 2007 [cited by applicant]
WO WO2008011725A1 · 2008 [cited by applicant]
WO WO2008024463A2 · 2008 [cited by applicant]
WO WO2008024463A3 · 2008 [cited by applicant]
WO WO2008127368A2 · 2008 [cited by applicant]
WO WO2008127368A3 · 2008 [cited by applicant]
WO WO2009114117A2 · 2009 [cited by applicant]
WO WO2009114117A3 · 2009 [cited by applicant]
WO WO2016023786A1 · 2016 [cited by applicant]
WO WO2016064750A1 · 2016 [cited by applicant]
WO WO2017048852A1 · 2017 [cited by applicant]
WO WO2017156316A1 · 2017 [cited by applicant]
WO WO2018093933A1 · 2018 [cited by applicant]
WO WO2018183748A1 · 2018 [cited by applicant]
WO WO2018222751A1 · 2018 [cited by applicant]
WO WO2019060764A1 · 2019 [cited by applicant]
WO WO2019160958A1 · 2019 [cited by applicant]
Extended European Search Report mailed on Jan. 24, 2024, for EP Application No. 23 160 060.2, filed on Mar. 9, 2009, 12 pages. [cited by applicant]
Non-Final Office Action mailed on Jan. 16, 2024, for U.S. Appl. No. 18/178,431, filed Mar. 3, 2023, 16 pages. [cited by applicant]
Notice of Allowance mailed on Dec. 13, 2023, for U.S. Appl. No. 17/375,586, filed Jul. 14, 2021, 12 pages. [cited by applicant]
Black, Q.C. et al. (2004). “Defining a Radiotherapy Target with positron emission tomography,” Int. J. Radiation Oncology Biol. Phys. 60:1272-1282. [cited by applicant]
Bortfield, T. et al. (2002). “Effects of intra-fraction motion on IMRT dose delivery: Statistical analysis and simulation,” Phys. Med. Biol. 47:2203-2220. [cited by applicant]
Chen, Y. et al. (2011). “Dynamic tomotherapy delivery,” Am. Assoc. Phys. Med. 38:3013-3024. [cited by applicant]
Corrected Notice of Allowability mailed on Mar. 10, 2020, for U.S. Appl. No. 16/138,631, filed Sep. 21, 2018, 4 pages. [cited by applicant]
Corrected Notice of Allowability mailed on Mar. 13, 2023, for U.S. Appl. No. 17/235,812, filed Apr. 20, 2021, 4 pages. [cited by applicant]
Corrected Notice of Allowability mailed on Mar. 16, 2023, for U.S. Appl. No. 17/203,532, filed Mar. 16, 2021, 2 pages. [cited by applicant]
Dieterich, S. et al. (2003). “Skin respiratory motion tracking for stereotactic radiosurgery using the CyberKnife,” Elsevier Int'l Congress Series 1256:130-136. [cited by applicant]
Erdi, Y.E. (2007). “The use of PET for radiotherapy,” [cited by applicant]
Extended European Search Report mailed on Mar. 31, 2017, for European Application No. 09 719 473.2, filed on Mar. 9, 2009, 8 pages. [cited by applicant]
Extended European Search Report mailed on Oct. 30, 2020, for EP Application No. 20 179 036.7, filed on Mar. 9, 2009, 12 pages. [cited by applicant]
Extended European Search Report mailed on May 19, 2021, for European Application No. 18 857 863.7, filed on Sep. 21, 2018, 7 pages. [cited by applicant]
Extended European Search Report mailed on Feb. 3, 2021, for European Application No. 18810297.4, filed on May 30, 2018, 4 pages. [cited by applicant]
Extended European Search Report mailed on Oct. 15, 2021, for European Application No. 19 754 923.1, filed on Feb. 13, 2019, 11 pages. [cited by applicant]
Extended European Search Report mailed on Jun. 23, 2023, for EP Application No. 20 840 804.7, filed on Jul. 2, 2020, 7 pages. [cited by applicant]
Final Office Action mailed on Aug. 15, 2012, for U.S. Appl. No. 13/209,275, filed Aug. 12, 2011, 8 pages. [cited by applicant]
Hunt, M.A. et al. (2003). “Treatment Planning Considerations using IMRT,” pp. 103-121. [cited by applicant]
International Search Report mailed on May 4, 2009, for PCT Application No. PCT/US2009/01500, filed on Mar. 9, 2009, 3 pages. [cited by applicant]
International Search Report mailed on Oct. 3, 2018, for PCT Application No. PCT/US2018/035188, filed on May 30, 2018, 4 pages. [cited by applicant]
International Search Report mailed on Apr. 23, 2020, for PCT Application No. PCT/US2020/013927, filed on Jan. 16, 2020, 3 pages. [cited by applicant]
International Search Report mailed on Jan. 18, 2019, for PCT Application No. PCT/US2018/052272, filed on Sep. 21, 2018, 4 pages. [cited by applicant]
International Search Report mailed on Jun. 14, 2019, for PCT Application No. PCT/US2019/017855, filed on Feb. 13, 2019, 4 pages. [cited by applicant]
Kapatoes, J. M. (2001). “On the accuracy and effectiveness of dose reconstruction for tomotherapy,” [cited by applicant]
Kim, B. et al. (2009). “Motion-induced dose artifacts in helical tomotherapy,” Phys. Med. Biol. 54:5707-5734. [cited by applicant]
Kissick, M.W. et al. (2008). “On the impact of longitudinal breathing motion randomness for tomotherapy delivery,” Phys. Med. Biol. 53:4855-4873. [cited by applicant]
Lu, W. (2008). “Real time motion-adaptive delivery (MAD) using binary MLC: II. Rotation beam (tomotherapy) delivery,” Phys. Med. Biol. 53:6513-6531. [cited by applicant]
Manikandan et al. (2013). “Role of step size and max dwell time in anatomy based inverse optimization for prostate implants,” J. Med. Phys. 38:148-154. [cited by applicant]
Moratal, D. et al. (2008). “ [cited by applicant]
Netherton, T. et al. (2017). “The Interplay effect when treating moving tumors using high-dose rate and increased MLC and Gantry Rotation speeds,” AAPM 59 [cited by applicant]
Non-Final Office Action mailed on Jan. 10, 2011, for U.S. Appl. No. 12/367,679, filed Feb. 9, 2009, 9 pages. [cited by applicant]
Non-Final Office Action mailed on Feb. 28, 2012, for U.S. Appl. No. 13/209,275, filed Aug. 12, 2011, 8 pages. [cited by applicant]
Non-Final Office Action mailed on Sep. 19, 2013, for U.S. Appl. No. 13/895,255, filed May 15, 2013, 8 pages. [cited by applicant]
Non-Final Office Action mailed on Dec. 6, 2019, for U.S. Appl. No. 15/993,325, filed May 30, 2018, 8 pages. [cited by applicant]
Non-Final Office Action mailed on Mar. 3, 2022, for U.S. Appl. No. 17/150,977, filed Jan. 15, 2021, 8 pages. [cited by applicant]
Non-Final Office Action mailed on Mar. 3, 2022, for U.S. Appl. No. 16/274,962, filed Feb. 13, 2019, 12 pages. [cited by applicant]
Non-Final Office Action mailed on Jul. 5, 2022, for U.S. Appl. No. 17/203,532, filed Mar. 16, 2021, 13 pages. [cited by applicant]
Non-Final Office Action mailed on Aug. 30, 2022, for U.S. Appl. No. 17/235,812, filed Apr. 20, 2021, 8 pages. [cited by applicant]
Non-Final Office Action mailed on May 26, 2023, for U.S. Appl. No. 17/877,719, filed Jul. 29, 2022, 7 pages. [cited by applicant]
Notice of Allowance mailed on Jul. 25, 2011, for U.S. Appl. No. 12/367,679, filed Feb. 9, 2009, 7 pages. [cited by applicant]
Notice of Allowance mailed on Apr. 9, 2014, for U.S. Appl. No. 13/895,255, filed May 15, 2013, 7 pages. [cited by applicant]
Notice of Allowance mailed on Oct. 27, 2015, for U.S. Appl. No. 14/278,973, filed May 15, 2014, 8 pages. [cited by applicant]
Notice of Allowance mailed on Mar. 27, 2013, for U.S. Appl. No. 13/209,275, filed Aug. 12, 2011, 9 pages. [cited by applicant]
Notice of Allowance mailed on Oct. 5, 2017, for U.S. Appl. No. 14/951,194, filed Nov. 24, 2015, 11 pages. [cited by applicant]
Notice of Allowance mailed on Apr. 4, 2019, for U.S. Appl. No. 15/807,383, filed Nov. 8, 2017, 11 pages. [cited by applicant]
Notice of Allowance mailed on Jan. 21, 2020, for U.S. Appl. No. 16/138,631, filed Sep. 21, 2018, 11 pages. [cited by applicant]
Notice of Allowance mailed on Apr. 20, 2020, for U.S. Appl. No. 15/993,325, filed May 30, 2018, 7 pages. [cited by applicant]
Notice of Allowance mailed on Nov. 19, 2020, for U.S. Appl. No. 16/814,867, filed Mar. 10, 2020, 10 pages. [cited by applicant]
Notice of Allowance mailed on Apr. 12, 2022, for U.S. Appl. No. 16/274,962, filed Feb. 13, 2019, 8 pages. [cited by applicant]
Notice of Allowance mailed on Jun. 15, 2022, for U.S. Appl. No. 17/150,977, filed Jan. 15, 2021, 8 pages. [cited by applicant]
Notice of Allowance mailed on Dec. 15, 2022, for U.S. Appl. No. 17/203,532, filed Mar. 16, 2021, 8 pages. [cited by applicant]
Notice of Allowance mailed on Feb. 1, 2023, for U.S. Appl. No. 17/235,812, filed Apr. 20, 2021, 7 pages. [cited by applicant]
Notice of Allowance mailed on Apr. 4, 2023, for U.S. Appl. No. 17/831,105, filed Jun. 2, 2022, 9 pages. [cited by applicant]
Notice of Allowance mailed on Jul. 5, 2023, for U.S. Appl. No. 17/831,105, filed Jun. 2, 2022, 7 pages. [cited by applicant]
Notice of Allowance mailed on Sep. 6, 2023, for U.S. Appl. No. 17/877,719, filed Jul. 29, 2022, 7 pages. [cited by applicant]
Salter, B.J. (2001). “NOMOS Peacock IMRT utilizing the Beak™ post collimation device,” Med. Dosim. 26:37-45. [cited by applicant]
Wang, D. et al. (2006). “Initial experience of FOG-PET/CT guided IMRT of head-and-neck carcinoma,” Int. J. Radiation Oncology Biol. Phys. 65:143-151. [cited by applicant]
Written Opinion of the International Searching Authority mailed on May 4, 2009, for PCT Application No. PCT/US2009/01500, filed on Mar. 9, 2009, 5 pages. [cited by applicant]
Written Opinion of the International Searching Authority mailed on Oct. 3, 2018, for PCT Application No. PCT/US2018/035188, filed on May 30, 2018, 28 pages. [cited by applicant]
Written Opinion of the International Searching Authority mailed on Jan. 18, 2019, for PCT Application No. PCT/US2018/052272, filed on Sep. 21, 2018, 14 pages. [cited by applicant]
Written Opinion of the International Searching Authority mailed on Jun. 14, 2019, for PCT Application No. PCT/US2019/017855, filed on Feb. 13, 2019, 10 pages. [cited by applicant]
Written Opinion of the International Searching Authority mailed on Apr. 23, 2020, for PCT Application No. PCT/US2020/013927, filed on Jan. 16, 2020, 4 pages. [cited by applicant]
Extended European Search Report mailed on Sep. 10, 2024, for EP Application No. 24 164 232.1, filed on Sep. 21, 2018, 8 pages. [cited by applicant]
Notice of Allowance mailed on May 9, 2024, for U.S. Appl. No. 17/571,273, filed Jan. 7, 2022, 15 pages. [cited by applicant]
Notice of Allowance mailed on Aug. 13, 2024, for U.S. Appl. No. 18/178,431, filed Mar. 3, 2023, 9 pages. [cited by applicant]
Supplemental Notice of Allowability mailed on Aug. 8, 2024, for U.S. Appl. No. 17/571,273, filed Jan. 7, 2022, 2 pages. [cited by applicant]